Enhancing Sterile Drug Quality with AI-Driven Inspection
By Christy Eatmon
February 9, 2026
Bringing speed, consistency, and insight to sterile drug inspection
3 min read
False
By Christy Eatmon
February 9, 2026
Bringing speed, consistency, and insight to sterile drug inspection
3 min read
By Dan Williams
February 6, 2026
AI, data-sharing, and gene technologies are peering into the future of rare disease drug development, and overcoming economic, regulatory, and diagnostic challenges for transformative therapies.
9 min read
By Chris Moore
February 5, 2026
Why people, process, and purpose matter most
5 min read
February 5, 2026
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
1 min read
By Andrew Lewis
January 20, 2026
Decades of research have made mRNA a platform for fast, flexible therapeutic innovation, but its promise depends on partnerships.
4 min read
January 20, 2026
Entrepreneur and philanthropist will assist South Texas Accelerated Research Therapeutics (START) in its quest to expand globally
2 min read
January 19, 2026
First-in-class monoclonal antibody agonist program for inflammation
2 min read
January 15, 2026
About the Pediatric Praziquantel Consortium, and why a child-friendly treatment for preschool-aged children with schistosomiasis was needed
13 min read
By Stephanie Vine
January 14, 2026
In short: Yes, says Mat Minardi, Chief Scientific Officer at Sterling Pharma Solutions
7 min read
By Mona-Elisabeth Rootwelt-Revheim
January 12, 2026
Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.
5 min read
False
False
False